Hydrocephalus Market Forecast To Reach $4.79 Billion By 2030: Key Growth Drivers And Industry Trends
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Hydrocephalus Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The hydrocephalus market size has exhibited strong growth in recent years. It is projected to expand from $3.66 billion in 2025 to $3.87 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.8%. This historical growth can be attributed to several factors, including improvements in neuroimaging availability, increased awareness of neurological conditions, the expansion of hospital neurology departments, the growth in pediatric neurosurgery practices, and the availability of diagnostic imaging infrastructure.
The hydrocephalus market is projected to experience substantial expansion over the upcoming years. By 2030, this market is expected to achieve a value of $4.79 billion, demonstrating a compound annual growth rate (CAGR) of 5.5%. This projected growth is driven by several factors, including greater investments in neurological research, a heightened demand for early diagnosis solutions, the proliferation of advanced imaging technologies, an increased emphasis on minimally invasive treatments, and enhanced funding for neurological healthcare. Key developments during this period encompass the wider application of advanced neuroimaging techniques, increased uptake of early diagnostic screening, a heightened focus on managing pediatric hydrocephalus, expanded clinical research into neurological disorders, and improved integration of data-driven diagnostic approaches.
Get A Free Sample Report With In-Depth Market Insights:
Hydrocephalus Market Expansion Drivers: What’s Shaping Future Growth?
The hydrocephalus market is anticipated to grow significantly in the coming years, driven by the swift expansion of healthcare infrastructure. Healthcare infrastructure encompasses the collective system of buildings, organizations, and resources dedicated to fostering, restoring, and maintaining health, comprising various interconnected components that work together to deliver medical services to individuals and communities. A well-developed healthcare infrastructure is essential for providing comprehensive and specialized treatment to patients with hydrocephalus, ensuring prompt diagnosis, adequate therapy, and ongoing care, all of which contribute to improved outcomes for those suffering from this ailment. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the United States had 6,129 hospitals, representing a 0.591% increase from 6,093 hospitals in 2022. Thus, the rapid development of healthcare infrastructure is propelling the hydrocephalus market.
Hydrocephalus Market Segment Trends And Revenue Contributors
The hydrocephalus market covered in this report is segmented –
1) By Type: Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus
2) By Age Group: Pediatric, Adult
3) By Diagnostics: MRI, CT Scan, Head Ultrasound, Other Diagnostics
4) By End User: Hospitals, Diagnostic Centers, Academic Institutions, Research Organizations
Subsegments:
1) By Congenital Hydrocephalus: Associated With Genetic Disorders, Associated With Neural Tube Defects
2) By Acquired Hydrocephalus: Post-Traumatic Hydrocephalus, Hydrocephalus Due To Tumors, Hydrocephalus Following Infection
3) By Normal-Pressure Hydrocephalus (NPH): Idiopathic Normal-Pressure Hydrocephalus, Secondary Normal-Pressure Hydrocephalus
Hydrocephalus Market Strategic Trends: What Defines The Next Growth Phase?
Prominent companies operating in the hydrocephalus market are developing innovative products, including endovascularly implantable cerebrospinal fluid (CSF) shunts, to improve the condition’s management by offering minimally invasive solutions that regulate CSF flow and alleviate intracranial pressure. An endovascularly implantable cerebrospinal fluid (CSF) shunt is a type of system inserted into blood vessels (endovascularly) to manage hydrocephalus, a disorder characterized by an excessive buildup of CSF in the brain. As an example, in August 2024, CereVasc Inc., a US-based clinical-stage medical device company, secured approval from the Food and Drug Administration (FDA), a US-based federal agency responsible for public health protection, for its eShunt System. The eShunt System is a medical device created for treating Normal Pressure Hydrocephalus (NPH). This system features an endovascularly implantable cerebrospinal fluid (CSF) shunt that aims to circumvent the requirement for invasive surgery and general anesthesia. The eShunt will be implanted under local anesthesia using a minimally invasive femoral venous approach, performed in a dedicated angiography suite.
Hydrocephalus Market Key Participants And Competitive Landscape
Major companies operating in the hydrocephalus market are Johnson & Johnson Corporation, Medtronic plc, MIZUHO Co. Ltd., B. Braun Melsungen AG, Helios Hospital, Texas Children’s Hospital, Boston Children’s Hospital, Karl Storz SE and Co. KG, Integra LifeSciences Corporation, Children’s National Hospital, Natus Medical Incorporated, Aesculap Inc., Sophysa SA, Anadolu Medical Center, Christoph Miethke GmbH & Co. KG, Moller Medical GmbH, Spiegelberg GmbH & Co. KG, Delta Surgical Limited, Kaneka Medix Corporation, Tokibo Co. Ltd.
View The Full Hydrocephalus Market Report:
Hydrocephalus Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the hydrocephalus market in 2025. The regions covered in the hydrocephalus market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
